Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q99706: Variant p.Val87Leu

Killer cell immunoglobulin-like receptor 2DL4
Gene: KIR2DL4
Feedback?
Variant information Variant position: help 87 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Valine (V) to Leucine (L) at position 87 (V87L, p.Val87Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 87 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 377 The length of the canonical sequence.
Location on the sequence: help GVPVPELYNRIFWNSFLISP V TPAHAGTYRCRGFHPHSPTE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 22 – 377 Killer cell immunoglobulin-like receptor 2DL4
Topological domain 22 – 242 Extracellular
Domain 44 – 104 Ig-like C2-type 1
Disulfide bond 51 – 97
Alternative sequence 27 – 121 Missing. In isoform 6.



Literature citations
NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains.
Selvakumar A.; Steffens U.; Dupont B.;
Tissue Antigens 48:285-294(1996)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS LEU-87; THR-138; ALA-209 AND HIS-371; Polymorphism and domain variability of human killer cell inhibitory receptors.
Selvakumar A.; Steffens U.; Dupont B.;
Immunol. Rev. 155:183-196(1997)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2); VARIANTS LEU-87; THR-138; ALA-209 AND HIS-371; Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103.
Selvakumar A.; Steffens U.; Palanisamy N.; Chaganti R.S.K.; Dupont B.;
Tissue Antigens 49:564-573(1997)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 3; 4 AND 5); VARIANTS LEU-87; THR-138; ALA-209; ASN-271 AND HIS-371;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.